Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CBD Life Sciences Inc. (CBDL) Message Board

$CBDL CBD Life Sciences Inc. (CBDL) in Final Stage

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 1087
(Total Views: 85)
Posted On: 01/14/2025 8:10:18 AM
Avatar
Posted By: louied91
$CBDL CBD Life Sciences Inc. (CBDL) in Final Stages to Sell CBD Products on DoorDash Platform


https://www.accesswire.com/967875/cbd-life-sc...h-platform

With DoorDash projecting over $10 billion in 2025 revenue, CBD Life Sciences Inc. is set to tap into one of the fastest-growing delivery markets in the country, potentially unlocking a multi-million dollar revenue stream and driving a projected 30-40% increase in annual revenue for CBDL.

SCOTTSDALE, ARIZONA / ACCESSWIRE / January 14, 2025 / CBD Life Sciences Inc. (OTC Pink:CBDL), a leading innovator in the CBD industry, proudly announces that it is in the final stages of securing approval to sell its premium CBD products on DoorDash, one of the most prominent on-demand delivery platforms in the United States. This development represents a significant step forward in CBDL's ongoing strategy to broaden its market reach and deliver high-quality CBD offerings to customers with greater convenience.

DoorDash's projected multi-billion-dollar revenue for 2025 underscores the massive growth potential in on-demand services. With a footprint spanning millions of households across the nation, DoorDash provides a unique and scalable avenue for CBDL to reach an even broader audience, enhancing product accessibility and driving exponential revenue growth. The CBD industry continues to surge, and this opportunity positions CBDL as a key player in transforming how consumers access wellness products.

"Being able to sell on DoorDash opens up an entirely new market for us," said Lisa Nelson, President and CEO of CBD Life Sciences Inc. "We are excited about the prospect of making our premium CBD products available through one of the most trusted delivery platforms in the U.S. This move not only aligns with our commitment to innovation but also positions us for substantial revenue growth in 2025 and beyond."

Once approved, CBDL plans to offer a wide range of its bestselling products, including high-potency 3000MG Pain Relief Cream and CBD Gummies, with same-day delivery in select markets. The company's CBD Gummies, known for their consistency and great taste, have been a hit with customers seeking convenient, delicious ways to incorporate wellness into their daily lives. This initiative enhances CBDL's competitive edge by catering to consumer demand for fast, convenient access to wellness products.

Expanding Market Potential and Growing Investor Confidence

In addition to expanding distribution channels, this opportunity also reinforces CBDL's aggressive growth strategy aimed at increasing shareholder value. Recent industry reports indicate that the U.S. CBD market is poised to grow at a compound annual growth rate (CAGR) of 28% over the next five years, driven by increased consumer awareness and demand for natural wellness solutions. With DoorDash's extensive logistics network and CBDL's premium product line, this expansion is expected to drive significant market penetration.

CBDL's focus on innovation doesn't stop at delivery partnerships. The company is also ramping up research and development efforts to introduce new products that cater to evolving consumer needs. These efforts reflect CBDL's dedication to staying ahead of market trends and ensuring sustained growth.

"This DoorDash opportunity is a game-changer," Nelson added. "It positions us at the forefront of a rapidly evolving market and gives us a significant advantage in capturing more market share while providing a seamless buying experience for our customers. We anticipate strong revenue growth and improved brand recognition as a direct result of this initiative."

CBDL continues to explore additional partnerships and opportunities to expand its reach in both the U.S. and international markets. With a strong product portfolio, a robust distribution strategy, and a relentless focus on growth, the company remains dedicated to delivering long-term value to its investors. Additionally, the company is committed to ongoing product innovation to meet the evolving needs of health-conscious consumers.


(0)
(0)




CBD Life Sciences Inc. (CBDL) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us